Related references
Note: Only part of the references are listed.Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona
Jordi Piella et al.
BIOCONJUGATE CHEMISTRY (2017)
Evaluating the potential of gold, silver, and silica nanoparticles to saturate mononuclear phagocytic system tissues under repeat dosing conditions
James L. Weaver et al.
PARTICLE AND FIBRE TOXICOLOGY (2017)
Size-Dependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives
Marie-Claude Senut et al.
SMALL (2016)
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Nardine S. Abadeer et al.
JOURNAL OF PHYSICAL CHEMISTRY C (2016)
Oxidative stress following exposure to silver and gold nanoparticles in mice
Rupal Shrivastava et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2016)
Application of gold nanoparticles in biomedical and drug delivery
Hadis Daraee et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
Highly sensitive pyrogen detection on medical devices by the monocyte activation test
Katharina Stang et al.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2014)
Intravascular blood sampling using the Thrombuster II catheter does not cause artifactual platelet activation
Gabrielle J. Pennings et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
The unexpected effect of PEGylated gold nanoparticles on the primary function of erythrocytes
Zeng He et al.
NANOSCALE (2014)
Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils
Zhenjia Wang et al.
NATURE NANOTECHNOLOGY (2014)
Mechanism and Cellular Kinetic Studies of the Enhancement of Antioxidant Activity by Using Surface-Functionalized Gold Nanoparticles
Libo Du et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies
Li Ma et al.
THROMBOSIS RESEARCH (2013)
Gold nanoparticles in biomedical applications: recent advances and perspectives
Lev Dykman et al.
CHEMICAL SOCIETY REVIEWS (2012)
Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells
Zhimin Liu et al.
NANOSCALE (2012)
Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans
Martin Ungerer et al.
CIRCULATION (2011)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Size-dependent tissue kinetics of PEG-coated gold nanoparticles
Wan-Seob Cho et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Critical parameters in the pegylation of gold nanoshells for biomedical applications: An in vitro macrophage study
James Chen Yong Kah et al.
JOURNAL OF DRUG TARGETING (2009)
Immunological properties of engineered nanomaterials
Marina A. Dobrovolskaia et al.
NATURE NANOTECHNOLOGY (2007)
Platelet activation in acute pulmonary embolism
T. Chung et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Nanoparticle-induced platelet aggregation and vascular thrombosis
A Radomski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Pegylation - A novel process for modifying pharmacokinetics
JM Harris et al.
CLINICAL PHARMACOKINETICS (2001)
Share Paper
